178 related articles for article (PubMed ID: 20890613)
1. Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue.
van de Nieuwenhof HP; de Hullu JA; Kaanders JH; Bulten J; Massuger LF; van Kempen LC
Virchows Arch; 2010 Dec; 457(6):693-703. PubMed ID: 20890613
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
Jonathan RA; Wijffels KI; Peeters W; de Wilde PC; Marres HA; Merkx MA; Oosterwijk E; van der Kogel AJ; Kaanders JH
Radiother Oncol; 2006 Jun; 79(3):288-97. PubMed ID: 16730088
[TBL] [Abstract][Full Text] [Related]
3. GLUT-1 expression is largely unrelated to both hypoxia and the Warburg phenotype in squamous cell carcinomas of the vulva.
Mayer A; Schmidt M; Seeger A; Serras AF; Vaupel P; Schmidberger H
BMC Cancer; 2014 Oct; 14():760. PubMed ID: 25306097
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
[TBL] [Abstract][Full Text] [Related]
5. Expression of endogenous hypoxia markers in vulvar squamous cell carcinoma.
Li YZ; Li SL; Li X; Wang LJ; Wang JL; Xu JW; Wu ZH; Gong L; Zhang XD
Asian Pac J Cancer Prev; 2012; 13(8):3675-80. PubMed ID: 23098453
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of hypoxia markers in T2-staged oral tongue cancer.
Roh JL; Cho KJ; Kwon GY; Ryu CH; Chang HW; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Jan; 45(1):63-8. PubMed ID: 18620902
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy.
De Schutter H; Landuyt W; Verbeken E; Goethals L; Hermans R; Nuyts S
BMC Cancer; 2005 Apr; 5():42. PubMed ID: 15847702
[TBL] [Abstract][Full Text] [Related]
8. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.
Kwon OJ; Park JJ; Ko GH; Seo JH; Jeong BK; Kang KM; Woo SH; Kim JP; Hwa JS; Carey TE
Head Neck; 2015 Apr; 37(4):505-10. PubMed ID: 24677746
[TBL] [Abstract][Full Text] [Related]
9. Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancer.
Kock L; Mahner S; Choschzick M; Eulenburg C; Milde-Langosch K; Schwarz J; Jaenicke F; Müller V; Woelber L
Int J Gynecol Cancer; 2011 Jan; 21(1):141-8. PubMed ID: 21330838
[TBL] [Abstract][Full Text] [Related]
10. Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
Huang WJ; Jeng YM; Lai HS; Fong IU; Sheu FY; Lai PL; Yuan RH
PLoS One; 2015; 10(3):e0119181. PubMed ID: 25738958
[TBL] [Abstract][Full Text] [Related]
11. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.
Winter SC; Shah KA; Han C; Campo L; Turley H; Leek R; Corbridge RJ; Cox GJ; Harris AL
Cancer; 2006 Aug; 107(4):757-66. PubMed ID: 16826581
[TBL] [Abstract][Full Text] [Related]
12. The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis.
Colpaert CG; Vermeulen PB; Fox SB; Harris AL; Dirix LY; Van Marck EA
Breast Cancer Res Treat; 2003 Sep; 81(2):137-47. PubMed ID: 14572156
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase IX in early-stage non-small cell lung cancer.
Kim SJ; Rabbani ZN; Vollmer RT; Schreiber EG; Oosterwijk E; Dewhirst MW; Vujaskovic Z; Kelley MJ
Clin Cancer Res; 2004 Dec; 10(23):7925-33. PubMed ID: 15585626
[TBL] [Abstract][Full Text] [Related]
14. Fibrotic focus and hypoxia in male breast cancer.
Kornegoor R; Verschuur-Maes AH; Buerger H; Hogenes MC; de Bruin PC; Oudejans JJ; Hinrichs B; van Diest PJ
Mod Pathol; 2012 Oct; 25(10):1397-404. PubMed ID: 22684218
[TBL] [Abstract][Full Text] [Related]
15. The role of Hypoxia-inducible factor-1 α , glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patients.
Sadlecki P; Bodnar M; Grabiec M; Marszalek A; Walentowicz P; Sokup A; Zegarska J; Walentowicz-Sadlecka M
Biomed Res Int; 2014; 2014():616850. PubMed ID: 24745019
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia, metabolism, and growth factor signaling in head and neck squamous cell carcinoma: correlation between primary and xenograft tumors.
Stegeman H; Rademakers SE; Span PN; Takes RP; van der Kogel AJ; Kaanders JH; Bussink J
Head Neck; 2014 Sep; 36(9):1288-95. PubMed ID: 24668936
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological implications of the expression of hypoxia-related proteins in gastric cancer.
Jung JH; Im S; Jung ES; Kang CS
Int J Med Sci; 2013; 10(9):1217-23. PubMed ID: 23935399
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of carbonic anhydrase IX (CAIX) in vulvar cancer is associated with tumor progression and development of locoregional lymph node metastases.
Choschzick M; Woelber L; Hess S; zu Eulenburg C; Schwarz J; Simon R; Mahner S; Jaenicke F; Müller V
Virchows Arch; 2010 May; 456(5):483-90. PubMed ID: 20358226
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue.
Kim SJ; Shin HJ; Jung KY; Baek SK; Shin BK; Choi J; Kim BS; Shin SW; Kim YH; Kim JS; Oosterwijk E
Jpn J Clin Oncol; 2007 Nov; 37(11):812-9. PubMed ID: 18057013
[TBL] [Abstract][Full Text] [Related]
20. Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells.
Rafajová M; Zatovicová M; Kettmann R; Pastorek J; Pastoreková S
Int J Oncol; 2004 Apr; 24(4):995-1004. PubMed ID: 15010840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]